Fingerprint
Dive into the research topics of 'Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non - Small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non - Small cell lung cancer
Alex A. Adjei, Julian R. Molina, Sumithra J. Mandrekar, Randolph Marks, Joel R. Reid, Gary Croghan, Lorelei J. Hanson, Ames R. Jett, Chenghua Xia, Chetan Lathia, Ronit Simantov
Research output: Contribution to journal › Article › peer-review
81
Scopus
citations